-
-
Toggle navigation
Frontiers journals are at the top of citation and impact metrics
Submit your manuscript
Scope
Molecular Diagnostics and Therapeutics serves as an international forum for the publication of significant basic, translational, and clinical research toward the identification of diagnostic and therapeutic tools for clinical use — e.g. biomarkers and new molecular targets, such as those identified through pharmacogenomics, epigenomics, proteomics, metabolomics assays and platforms.
Scope
Molecular Diagnostics and Therapeutics serves as an international forum for the publication of significant basic, translational, and clinical research toward the identification of diagnostic and therapeutic tools for clinical use — e.g. biomarkers and new molecular targets, such as those identified through pharmacogenomics, epigenomics, proteomics, metabolomics assays and platforms.
Drawing from a broad range of subdisciplines, Molecular Diagnostics and Therapeutics publishes the works describing technological advances in the detection and monitoring of the molecular causes of disease, including infectious and genetic diseases and cancer; the use of biomarkers to guide drug development and target patient groups for personalized medicine; the latest discoveries toward understanding the effects of genetic variations on drug response, drug metabolism, adverse events, and disease progression; the advancement and improvement of drug and diagnostic co-developments; the application of diagnostic methodologies and therapeutics in clinical trials; emerging new or improved molecular technologies and approaches for the diagnosis, monitoring or treatment of disease; as well as regulatory and ethical issues in molecular diagnostics. On the other hand, novel vehicles (e.g. multifunctional nanoconstructs and nanoparticulate drug carriers) for molecular therapies are also of great interest. Furthermore, with the wide-spread application of functional genomics for precision medicine (e.g. CRISPR), we are opening a new horizon in gene therapy. Molecular Diagnostics and Therapeutics also provides information about the growing number of diagnostic tests and therapeutics being approved or reaching late stage clinical development. Our ultimate goal is to accelerate communication and foster momentum in all aspects of molecular diagnostics and therapeutics.
Indexed in: PubMed, PubMed Central, Scopus, Google Scholar, DOAJ, CrossRef, Science Citation Index Expanded, CLOCKSS
PMCID: all published articles receive a PMCID
Molecular Diagnostics and Therapeutics welcomes submissions of the following article types: Brief Research Report, Correction, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review and Technology and Code.
All manuscripts must be submitted directly to the section Molecular Diagnostics and Therapeutics, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section Molecular Diagnostics and Therapeutics will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Molecular Biosciences.
Frontiers Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
Frontiers Support
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
support@frontiersin.org
There are no results to display.
Click on any of the keywords to find further editors related to it.
- Article(s) found
- Latest
- Most viewed
This section has no articles.
There are no articles to display. Please try changing the filters.
- Research Topic(s) found
- Latest
- Most viewed
Contact Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact molecularbiosciences.editorial.office@frontiersin.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact molecularbiosciences@frontiersin.org
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
For technical issues, please visit our Frontiers Help Center, or contact our IT HelpDesk team at support@frontiersin.org